PubRank

J F Moorhead

Author PubWeight™ 124.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Functional anatomy of the lymphocyte in immunological reactions in vitro. J Exp Med 1966 2.91
2 A collaborative scheme for tissue typing and matching in renal transplantation. Lancet 1969 2.26
3 Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982 1.98
4 Factors affecting the reactivity of human lymphocytes in vitro. I. Cell number, duration of culture and surface area. J Immunol 1967 1.96
5 Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int 2001 1.71
6 Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J 1975 1.61
7 Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet 1980 1.60
8 Abdominal hernias in patients receiving continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) 1981 1.59
9 Cancer in patients receiving dialysis. Br Med J 1980 1.52
10 The polyneuropathy of chronic renal failure. Brain 1971 1.49
11 Influence of HLA matching and blood-transfusion on outcome of 502 London Transplant Group renal-graft recipients. Lancet 1976 1.47
12 Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant 1989 1.39
13 Cyclosporin-induced renal magnesium leak in renal transplant patients. Nephrol Dial Transplant 1990 1.38
14 Influence of HL-A matching antigenic strength, and immune responsiveness on outcome of 349 cadaver renal grafts. 3 years' experience of the London transplant group. Lancet 1972 1.36
15 Sixteen months experience with cyclosporin-A in human kidney transplantation. Transplant Proc 1981 1.35
16 Atherosclerotic renovascular disease causing renal impairment--a case for treatment. Clin Nephrol 1989 1.28
17 Multicentre collaboration in 162 tissue-typed renal transplants. The London and Regional Transplant Group, March, 1969, to December, 1970. Lancet 1971 1.25
18 Hepatitis-associated antigen and antibody in haemodialysis patients and staff. Br Med J 1970 1.23
19 Rhabdomyolysis and systemic infection. Br Med J (Clin Res Ed) 1983 1.22
20 Glycosylated haemoglobin in chronic renal failure. Br Med J 1979 1.16
21 Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int 1981 1.15
22 Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J (Clin Res Ed) 1982 1.13
23 Lymphoid inhibitor of human lymphocyte DNA synthesis and mitosis in vitro. Nature 1969 1.11
24 Thrombotic thrombocytopenic purpura. Recovery after splenectomy. Arch Intern Med 1966 1.11
25 Home dialysis in children and adolescents. Proc Eur Dial Transplant Assoc 1972 1.09
26 Plasma hydroxyproline in renal osteodystrophy. Proc Eur Dial Transplant Assoc 1973 1.04
27 Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy. Lancet 1976 1.03
28 Efficiency of scintillation counting of tritium labelled DNA-protein in the mixed leucocyte reaction in vitro. Nature 1966 1.02
29 Disorders of blood-lipids in renal disease. Lancet 1975 0.99
30 Rejection encephalopathy. Proc Eur Dial Transplant Assoc 1981 0.98
31 Vitamin A toxicity and hypercalcaemia in chronic renal failure. Br Med J (Clin Res Ed) 1981 0.97
32 Parathyroid hormone as a causative factor of primary non-function in renal transplants. Br Med J (Clin Res Ed) 1988 0.97
33 Significance of high plasma renin activity in patients on maintenance haemodialysis therapy. Br Med J 1973 0.96
34 Captopril-enhanced 99mTc DTPA scintigraphy in the detection of renal-artery stenosis. Nephrol Dial Transplant 1988 0.96
35 Plasma renin activity and blood pressure in 89 patients receiving maintenance haemodialysis therapy. Br Med J 1972 0.95
36 Gut hormones and glomerular hyperfiltration. Lancet 1984 0.94
37 Acute tubular necrosis due to rhabdomyolysis and pancreatitis associated with Salmonella enteritidis food poisoning. Nephrol Dial Transplant 1993 0.94
38 Hypophosphataemic osteomalacia after cadaveric renal transplantation. Lancet 1974 0.93
39 Plasma immunoreactive melanotrophic hormones in patients on maintenance haemodialysis. Br Med J 1975 0.92
40 Gastrointestinal complications of dialysis related amyloidosis. BMJ 1988 0.91
41 Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant 1998 0.90
42 Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int 1993 0.90
43 Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol 1991 0.89
44 Plasma calcium and magnesium fractions in chronic-renal-failure patients on maintenance haemodialysis. Lancet 1973 0.89
45 Rejection encephalopathy. An acute neurological syndrome complicating renal transplantation. J Neurol Sci 1982 0.89
46 Three years' experience of continuous ambulatory peritoneal dialysis. Lancet 1981 0.89
47 Rejection encephalopathy. Lancet 1982 0.88
48 An epidemic of hepatitis in a renal dialysis unit. Proc R Soc Med 1971 0.88
49 Prognosis of critically-ill patients with acute renal failure: APACHE II score and other predictive factors. Q J Med 1989 0.88
50 Gastric function and histology in chronic renal failure. J Clin Pathol 1979 0.88
51 Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients. Kidney Int 1984 0.87
52 Selective effect of low protein diets in chronic renal diseases. Br Med J (Clin Res Ed) 1984 0.87
53 Evolution of bone disease over 10 years in 135 patients with terminal renal failure. Br Med J 1973 0.87
54 Human mesangial cells express inducible macrophage scavenger receptor. Kidney Int 1999 0.86
55 Minimal-change glomerular nephritis. Normal kidneys in an abnormal environment? Transplantation 1994 0.85
56 ACE inhibitors. Lancet 1988 0.85
57 Cyclosporine A enhances platelet aggregation. Kidney Int 1987 0.85
58 Tubular lipidosis: epiphenomenon or pathogenetic lesion in human renal disease? Kidney Int 1994 0.85
59 Can urinary thyroid hormone loss cause hypothyroidism? Lancet 1991 0.85
60 Paradoxical increase in nitric oxide synthase activity in hypercholesterolaemic rats with impaired renal function and decreased activity of nitric oxide. Nephrol Dial Transplant 2001 0.84
61 Regulation of lipoprotein trafficking in the kidney: role of inflammatory mediators and transcription factors. Biochem Soc Trans 2004 0.84
62 Dissociation of absorptions of calcium and phosphate after successful cadaveric renal transplantation. Br Med J 1979 0.84
63 Screening for renovascular disease with captopril-enhanced renography. Nephrol Dial Transplant 1992 0.84
64 Plasma renin activity (PRA) in 89 patients on regular haemodialysis. Proc Eur Dial Transplant Assoc 1972 0.83
65 Convulsions associated with cyclosporin A in renal transplant recipients. Br Med J (Clin Res Ed) 1985 0.83
66 How complete is a total parathyroidectomy in uraemia? Br Med J (Clin Res Ed) 1987 0.83
67 Comparison of radioisotope methods for the measurement of phosphate absorption in normal subjects and in patients with chronic renal failure. Clin Sci (Lond) 1981 0.83
68 Effects of age, sex, and polycystic disease on progressive bone disease of renal failure. Br Med J 1974 0.82
69 Long-term effects of small doses of 1,25-dihydroxycholecalciferol in renal osteodystrophy. Lancet 1978 0.82
70 Plasma hydroxyproline fractions in patients with dialysis osteodystrophy. Clin Chim Acta 1981 0.82
71 International collaboration in renal transplantation. Lancet 1971 0.81
72 Fat clearance before and after heparin in chronic renal failure--haemodialysis reduces post-heparin fractional clearance rates of intralipid. Clin Chim Acta 1980 0.81
73 Inhibition of DNA synthesis by guanidine compounds in uraemia. Proc Eur Dial Transplant Assoc 1975 0.81
74 Fenclofenac induced interstitial nephritis confirmed by inadvertent rechallenge. Br Med J (Clin Res Ed) 1985 0.81
75 Plasma triglyceride secretion and metabolism in chronic renal failure. Clin Chim Acta 1977 0.81
76 Lipoprotein(a) in patients with proteinuria. Nephrol Dial Transplant 1992 0.81
77 Glycosylated haemoglobin in chronic renal failure and after renal transplantation. J Clin Pathol 1982 0.80
78 Vitamin-D analogues and renal function. Lancet 1978 0.80
79 Differential ability of cells to promote oxidation of low density lipoproteins in vitro. Clin Chim Acta 1998 0.80
80 Serum parathyroid hormone concentration in chronic renal failure patients on maintenance haemodialysis. Clin Chim Acta 1974 0.80
81 Lipiduria in renal disease. Am J Hypertens 1993 0.80
82 The enhancing and sensitizing effects of donor blood components, including dendritic cells, in a rat renal allograft model. Transplantation 1984 0.80
83 In vitro cyclosporine toxicity. The effect of verapamil. Transplantation 1989 0.80
84 Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10. Tissue Antigens 2004 0.80
85 Human calcitonin in the treatment of renal osteodystrophy. J Lab Clin Med 1980 0.80
86 Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells. Kidney Int 1994 0.80
87 Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal? Clin Chim Acta 1981 0.79
88 Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. Br Med J (Clin Res Ed) 1986 0.79
89 Letter: Secondary haemorrhage after renal transplantation. Lancet 1976 0.79
90 Focal glomerular sclerosis and nephrotic syndrome with partial lecithin:cholesterol acetyltransferase deficiency and discoidal high density lipoprotein in plasma and urine. Lancet 1983 0.79
91 Dietary fish oil supplements preserve renal function in renal transplant recipients with chronic vascular rejection. Nephrol Dial Transplant 1989 0.79
92 Serum IgG and renal transplantation. Br Med J 1973 0.79
93 In-vitro inhibition of D.N.A. synthesis in human leukaemic cells by a lymphoid cell extract. Lancet 1970 0.79
94 Is there a time factor in renal allograft rejection? Br Med J 1979 0.79
95 Plasma lipids in patients with chronic renal failure. Clin Chim Acta 1973 0.79
96 Infection in the renal transplant patient. J R Soc Med 1978 0.79
97 Plasma lecithin-cholesterol acyltransferase activities in uraemic patients. Clin Chim Acta 1982 0.78
98 Characterisation of the binding of low-density lipoproteins to cultured rat mesangial cells. Nephrol Dial Transplant 1991 0.78
99 Comparison of continuous arteriovenous haemofiltration and haemodialysis in acute renal failure. Lancet 1988 0.78
100 Apolipoprotein B turnover in dialysis patients: its relationship to pathogenesis of hyperlipidemia. Clin Nephrol 1989 0.78
101 Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal. Clin Nephrol 1982 0.78
102 Survival rates of patients treated by home and hospital dialysis and cadaveric renal transplantation. Br Med J 1970 0.78
103 Heterogeneity of HLA-DR+ cells in normal human kidney. Immunohistological and cytochemical characterisation of discrete cell populations. J Clin Pathol 1983 0.78
104 Oxidation of low-density lipoproteins by rat mesangial cells and the interaction of oxidized low-density lipoproteins with rat mesangial cells in vitro. Nephrol Dial Transplant 1993 0.78
105 Controlled trial of azathioprine and cyclosporin to prevent anti-HLA antibodies due to third-party transfusion. Nephrol Dial Transplant 1988 0.77
106 The role of multiple pharmaco-therapy in the pathogenesis of hyperlipidemia after renal transplantation. Clin Nephrol 1981 0.77
107 Effect of cyclosporin A on endothelin synthesis by cultured human renal cortical epithelial cells. Nephrol Dial Transplant 1993 0.77
108 Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients. Kidney Int Suppl 1999 0.77
109 Low-dose simvastatin is safe in hyperlipidaemic renal transplant patients. Nephrol Dial Transplant 1993 0.77
110 Significance of cytokine gene polymorphism in renal transplantation. Transplant Proc 2001 0.77
111 Effect of 24,25-dihydroxycholecalciferol on intestinal absorption of calcium and phosphate and on parathyroid hormone secretion in chronic renal failure. Nephron 1992 0.76
112 The PPARalpha ligand fenofibrate: meeting multiple targets in diabetic nephropathy. Kidney Int 2006 0.76
113 Plasmapheresis in the haemolytic-uraemic syndrome in children. Br Med J (Clin Res Ed) 1981 0.76
114 Comparison of home dialysis and other treatments for chronic renal failure. Practitioner 1974 0.76
115 Hepatic metabolism of vitamin D in chronic renal failure. Lancet 1979 0.76
116 Effect of oral 1,25 dihydroxycholecalciferol on calcium and phosphate malabsorption in primary biliary cirrhosis. Gut 1979 0.76
117 Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine. Clin Nephrol 1999 0.76
118 Monitoring aminoglycoside use in patients with severely impaired renal function. Br Med J 1978 0.76
119 Nephrotoxicity of ionic and non-ionic contrast material in digital vascular imaging and selective renal arteriography. Br J Radiol 1983 0.76
120 Predicting plasma concentrations of common biochemical values from residual peritoneal fluid in patients on peritoneal dialysis. Br Med J 1978 0.75
121 Effects of oral propranolol on parathyroid hormone secretion in chronic renal failure. Br Med J 1980 0.75
122 Percutaneous renal biopsy in the sitting position. Br Med J 1966 0.75
123 Conversion of stable renal allografts at one year from cyclosporin A to azathioprine: a randomized controlled study. Transpl Int 1990 0.75
124 Diuretic escape and rebound oedema in renal allograft recipients. Br Med J 1979 0.75
125 Hypophosphataemia after parathyroidectomy in chronic renal failure. Br Med J (Clin Res Ed) 1982 0.75
126 Digital vascular imaging and selective renin sampling in evaluation of vascular anatomy in renal transplant recipients. Br Med J (Clin Res Ed) 1983 0.75
127 Captopril in hypertension after renal transplantation. Postgrad Med J 1984 0.75
128 Letter: Hypophosphataemic osteomalacia in patients receiving haemodialysis. Br Med J 1976 0.75
129 Nocturnal polyuria and saluresis in renal allograft recipients. Br Med J 1980 0.75
130 Tertiary hyperparathyroidism with adenoma formation after renal transplantation. Br Med J 1978 0.75
131 Lithium nephrotoxicity and red cell lithium. Nephrol Dial Transplant 1990 0.75
132 Nephrotic syndrome and simvastatin. Lancet 1990 0.75
133 Tuberculous peritonitis complicating peritoneal dialysis: a case for early diagnostic laparotomy? Nephrol Dial Transplant 1992 0.75
134 Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders. Adv Exp Med Biol 1977 0.75
135 Effects of diets with high carbohydrate content on diabetic hyperlipidaemia and microalbuminuria. Diabetes Res Clin Pract 1988 0.75
136 Urinary chloride excretion in suspected Bartter's syndrome. N Engl J Med 1979 0.75
137 Resolution of secondary hyperparathyroidism after cadaveric renal allograft. Proc Eur Dial Transplant Assoc 1975 0.75
138 Renal transplantation after removal of anti-HLA antibodies. Lancet 1984 0.75
139 Schistosomiasis in renal transplantation. Br J Urol 1982 0.75
140 Calcium set point progressively worsens in hemodialysis patients despite conventional oral 1-alpha hydroxycholecalciferol supplementation. Clin Nephrol 1993 0.75
141 Proceedings: Lung function in renal failure and transplantation. Clin Sci Mol Med 1974 0.75
142 In situ renal perfusion. Br J Urol 1972 0.75
143 Fat clearances and hyperlipidaemia in renal allograft recipients--the role of insulin resistance. Clin Chim Acta 1981 0.75
144 An in vitro model of nephrocalcinosis using rabbit inner medullary collecting tubular cell culture. Biochem Biophys Res Commun 1989 0.75
145 Effects of low-density lipoproteins on mesangial cell growth and viability in vitro. Nephrol Dial Transplant 1990 0.75
146 Human mesangial cells express inducible macrophage scavenger receptor: an Ap-1 and ets mediated response. Kidney Int Suppl 1999 0.75
147 Ureteric implantation in renal transplantation. A technical modification. Br J Urol 1972 0.75
148 LDL receptor gene expression in human mesangial cells under the influence of calcium channel blockers. Clin Nephrol 1999 0.75
149 The response to 1,25-dihydroxycholecalciferol and to dihydrotachysterol in adult-onset hypophosphataemic osteomalacia. Clin Chim Acta 1979 0.75
150 Proceedings: Plasma immunoreactive 'beta-melanocyte-stimulating hormone' in patients on maintenance dialysis. J Endocrinol 1975 0.75
151 Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients. Transplant Proc 2001 0.75
152 Use of metolazone, a new diuretic, in patients with renal disease. Nephron 1974 0.75
153 Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults. Nephrol Dial Transplant 1988 0.75
154 How to measure cyclosporin. Lancet 1984 0.75
155 Blood transfusion for renal transplantation: benefits and risks. Kidney Int Suppl 1983 0.75
156 Hepatitis B and the dialysis and renal transplantation unit. Nephron 1981 0.75
157 HDL cholesterol and intravenous fat tolerance in dialysis patients. Proc Eur Dial Transplant Assoc 1980 0.75
158 Successful renal transplantation with cadaveric donor kidneys of extremely prolonged cold ischaemic time. Nephrol Dial Transplant 1987 0.75
159 Preoperative ATG bolus treatment increase CsA sensitivity of peripheral blood lymphocytes (PBLS) in renal transplant patients. Transplant Proc 1999 0.75
160 Plasma lipoprotein patterns in patients receiving dialysis therapy for chronic renal failure. Clin Chim Acta 1977 0.75
161 Lipopheresis in the nephrotic syndrome. Kidney Int Suppl 1999 0.75
162 Plasma LCAT activities in renal allograft recipients. Clin Chim Acta 1982 0.75
163 Successful renal transplantation despite a positive fluorescence-activated cell sorter crossmatch following plasma exchange of donor-specific anti-HLA antibodies. Transplantation 1986 0.75
164 Digital vascular imaging and selective renin sampling in post-transplant hypertension. Which kidney is responsible? Clin Nephrol 1983 0.75
165 Evaluation of Coomassie dye binding method for microprotein assay in diabetic proteinuria. Ann Clin Res 1986 0.75
166 Improvement of blood flow in transplanted kidneys in dogs using a frusemide-added perfusate. Transplantation 1973 0.75
167 Enhancement of renal blood flow in transplanted dog kidneys following perfusion with frusemide. Scott Med J 1974 0.75
168 Comparison of oral and intravenous cyclosporine A in kidney transplants. Transplant Proc 1987 0.75
169 Renal osteodystrophy: dietary influences and management. Proc Nutr Soc 1979 0.75
170 Atherosclerosis in dialysis and renal-transplant patients. Lancet 1980 0.75
171 Dialysis induces cyclosporine a resistance: induction therapy with bolus ATG-Fresenius increases cyclosporine sensistivity. Transplant Proc 2003 0.75
172 Blood cyclosporin concentrations and renal allograft dysfunction. Br Med J (Clin Res Ed) 1986 0.75
173 Renal transplant policy. Lancet 1981 0.75
174 Parathyroid suppressibility in renal osteodystrophy. Proc Eur Dial Transplant Assoc 1975 0.75
175 Reduction of serum prolactin after salmon calcitonin infusion in patients with impaired renal function. Acta Endocrinol (Copenh) 1987 0.75
176 Acute megaloblastosis due to cotrimoxazole. Br J Clin Pract 1980 0.75
177 Radiographic changes of renal osteodystrophy in 135 haemodialysis patients. Proc Eur Dial Transplant Assoc 1973 0.75
178 Induction of immunological unresponsiveness by multiple blood transfusion in uraemic patients. Lancet 1981 0.75
179 Hyperlipidemia in nephrotic syndrome. Am J Nephrol 1989 0.75
180 Epstein-Barr-virus-associated lymphoproliferation arising in a renal allograft. Nephron 1989 0.75
181 Do plasma triglycerides regulate high-density lipoproteins or vice versa? Lancet 1979 0.75
182 Post-heparin hepatic and lipoprotein lipase activities in nephrotic syndrome. Aust N Z J Med 1984 0.75
183 Logistic regression model for the assessment of microalbuminuria and microproteinuria in insulin-dependent diabetic patients at risk. Comput Methods Programs Biomed 1989 0.75
184 Lipids in CAPD: a review. Contrib Nephrol 1990 0.75
185 The clinical application of a rapid diagnostic test for the detection of cytomegalovirus infection in renal transplant recipients. Transplant Proc 1987 0.75
186 Home haemodialysis in children. Report of the London Children's Home Dialysis Group. Lancet 1977 0.75
187 Review of ten years' home dialysis. Proc Eur Dial Transplant Assoc 1975 0.75
188 The effects of vitamin A toxicity on calcium and lipid metabolism in chronic renal failure. Proc Eur Dial Transplant Assoc 1981 0.75
189 Granulomatous sarcoid nephritis presenting as frank haematuria. Nephrol Dial Transplant 1994 0.75
190 Spontaneous rupture of nephrostomy-drained renal transplant. Br J Urol 1986 0.75
191 Therapeutic interactions in terminal renal failure. Nephron 1974 0.75
192 The present status of haemodialysis. Practitioner 1971 0.75
193 Cyclosporin inhibition of glucose transport in cell culture. Transplant Proc 1989 0.75
194 A "European Institute of Health". Lancet 1992 0.75
195 Hepatic malignancy after renal transplantation in an HBsAg positive patient. Br J Clin Pract 1980 0.75
196 Increased expression of Ia (HLA-DR) antigens in rejecting kidneys. Lancet 1984 0.75
197 Oxidizability of low-density lipoproteins from Neoral and tacrolimus-treated renal transplant patients. Transplant Proc 1998 0.75
198 Preliminary experience with cyclosporin A in human renal allografts. Transplant Proc 1980 0.75
199 Cefuroxime pharmacokinetics in continuous and intermittent peritoneal dialysis. Nephron 1985 0.75
200 Response patterns to DL-carnitine in patients on maintenance haemodialysis. Nephron 1982 0.75
201 Lysophosphatidylcholine induces platelet-derived growth factor gene expression in a human mesangial cell line. Kidney Int Suppl 1999 0.75
202 Dissociation between calcium and phosphate absorption in nephrotic syndrome. Clin Sci (Lond) 1983 0.75
203 Effects of dietary fatty acids in an animal model of focal glomerulosclerosis. Kidney Int 1991 0.75